Division of Psychosocial Oncology, Cumming School of Medicine, University of Calgary, 3330 Hospital Dr. NW, Calgary, AB, T2N 4N1, Canada.
Department of Psychosocial Oncology, Tom Baker Cancer Centre-Holy Cross Site, 2202 2nd Street SW, Calgary, AB, T2S 3C1, Canada.
J Cancer Surviv. 2020 Jun;14(3):261-272. doi: 10.1007/s11764-019-00838-x. Epub 2019 Dec 18.
Gastrointestinal (GI) cancer patients often suffer high rates of distress and social isolation, partially due to symptoms that are embarrassing or difficult to discuss with family or friends. Group support therapies mitigate illness-related stigma and standardization; however, men, in particular, are more averse to joining. Through an ongoing men-only GI cancer support group, this study sought to understand who joined the groups, what facilitated group uptake, and explore men's reasons for enrolling in the group.
A mixed-methods study design and analysis were used. A qualitative design utilizing open-ended, semi-structured interviews and thematic analysis were used; Theory of Planned Behavior (TPB) directed the inquiry towards facets of group uptake. Standardized measures were also used to assess distress, coping, and quality of life (QoL) and compared with normative values for cancer and general population. Data from qualitative and quantitative findings were triangulated.
Participants included 35 male GI cancer patients, aged 28-72, at varying stages of illness and treatment. Themes related to group uptake and enrollment were endorsement; composition; and attitudes, and reasons for joining were learning new coping techniques and affiliations with similar others. Men's QoL and psychological distress scores were on par with cancer patient norms. The scores obtained from quantitative scales corroborated with our qualitative findings.
Despite psychosocial, demographic, and clinical variations, participants were keen on joining a male-only Supportive-Expressive Therapy (SET) group to address their emotional, informational, and supportive care needs and express their solidarity for other patients.
Findings bear clinical relevance for designing GI male-centered group formats that endorse men's needs and facilitate their accessibility to group support interventions.
胃肠道(GI)癌症患者经常遭受高比例的痛苦和社会孤立,部分原因是症状令人尴尬或难以与家人或朋友讨论。团体支持疗法减轻了与疾病相关的耻辱感和标准化;然而,男性,特别是,更不愿意加入。通过一个正在进行的仅限男性的胃肠道癌症支持小组,本研究旨在了解谁加入了这些小组,是什么促进了小组的参与,以及探索男性加入小组的原因。
采用混合方法研究设计和分析。使用定性设计,采用开放式、半结构化访谈和主题分析;计划行为理论(TPB)指导了对小组参与度的各个方面的探究。还使用了标准化措施来评估痛苦、应对和生活质量(QoL),并将其与癌症和一般人群的正常值进行比较。定性和定量发现的数据进行了三角剖分。
参与者包括 35 名年龄在 28-72 岁之间的胃肠道癌症男性患者,处于不同的疾病和治疗阶段。与小组参与和参与有关的主题包括认可、组成和态度,以及加入的原因是学习新的应对技巧和与相似的人建立联系。男性的生活质量和心理困扰评分与癌症患者的正常值相当。定量量表获得的分数与我们的定性发现相符。
尽管存在社会心理、人口统计学和临床方面的差异,参与者还是热衷于参加仅限男性的支持性表达疗法(SET)小组,以满足他们的情感、信息和支持性护理需求,并表达他们对其他患者的团结。
研究结果对设计以胃肠道为中心的男性小组格式具有临床意义,这些格式认可男性的需求,并促进他们获得团体支持干预的机会。